% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Zwicker:168307,
author = {F. Zwicker$^*$ and S. Hoefel and C. Kirchner and P. E.
Huber$^*$ and J. Debus$^*$ and M. Schempp},
title = {{H}ypofractionated {R}adiotherapy {W}ith
{S}imultaneous-integrated {B}oost {A}fter
{B}reast-conserving {S}urgery {C}ompared to {S}tandard
{B}oost-applications {U}sing {H}elical {T}omotherapy {W}ith
{T}omo{E}dge.},
journal = {Anticancer research},
volume = {41},
number = {4},
issn = {1791-7530},
address = {Attiki},
reportid = {DKFZ-2021-00818},
pages = {1909 - 1920},
year = {2021},
note = {#EA:E055#},
abstract = {This comparative plan study examines a range of
boost-radiation methods in adjuvant radiotherapy of breast
cancer using helical intensity-modulated radiotherapy with
TomoEdge-technique. Impact of hypofractionated radiation
with simultaneous-integrated boost (SIB) and influence of
differing assumed α/β-values were examined.For 10 patients
with left-sided breast cancer each four helical IMRT-plans
with TomoEdge-technique were created: hypofractionated+SIB
(H-SIB) (42.4/54.4 Gy, 16 fractions), normofractionated+SIB
(N-SIB) (50.4/64.4 Gy, 28 fractions),
hypofractionated+sequential-boost (H-SB) (42.4 Gy/16
fractions+16 Gy/8 fractions), normofractionated+
sequential-boost (N-SB) (50.4 Gy/28 fractions+16 Gy/8
fractions). Equivalent doses (EQD2) to organs-at-risk (OAR)
and irradiated mammary-gland were analysed for different
assumed α/β-values.The mean EQD2 to OAR was significantly
lower using hypofractionated radiation-techniques. H-SIB and
H-SB were not significantly different. H-SIB and N-SIB
conformed significantly better to the breast planning-target
volume (PTV) and boost-volume (BV) than H-SB and N-SB.
Regarding BV, mean EQD2 was significantly higher for all
α/β-values investigated when using H-SIB and N-SIB.
Regarding PTV, there were no clinically relevant
differences.Relating to dosimetry, H-SIB is effective
compared to standard-boost-techniques.},
keywords = {Hypofractionated radiotherapy (Other) / IMRT (Other) / SIB
(Other) / TomoEdge (Other) / breast cancer (Other) / helical
tomotherapy (Other) / simultaneous integrated boost (Other)},
cin = {E055 / E050},
ddc = {610},
cid = {I:(DE-He78)E055-20160331 / I:(DE-He78)E050-20160331},
pnm = {315 - Bildgebung und Radioonkologie (POF4-315)},
pid = {G:(DE-HGF)POF4-315},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:33813396},
doi = {10.21873/anticanres.14957},
url = {https://inrepo02.dkfz.de/record/168307},
}